OGER, JOEL: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study

Kingwell, Elaine, Zhu, Feng, Evans, Charity, Duggan, Thomas, Oger, Joel, Tremlett, Helen

Journal:

Neuroepidemiology

Year:

2019

File:

PDF, 173 KB

2019

2

Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing

Alkhawajah, Nuha M., Oger, Joel

Journal:

Year:

2013

Language:

english

File:

PDF, 380 KB

english, 2013

3

Où allons-nous avec les traitements de la SEP? Les coûts vont-ils continuer à augmenter ?*

Oger, Joel, AlKhawajah, Mona

Journal:

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Year:

2010

Language:

french

File:

PDF, 44 KB

french, 2010

4

Randomized Trial of Thymectomy in Myasthenia Gravis

Wolfe, Gil I., Kaminski, Henry J., Aban, Inmaculada B., Minisman, Greg, Kuo, Hui-Chien, Marx, Alexander, Ströbel, Philipp, Mazia, Claudio, Oger, Joel, Cea, J. Gabriel, Heckmann, Jeannine M., Evoli, Am

Journal:

New England Journal of Medicine

Year:

2016

Language:

english

File:

PDF, 277 KB

english, 2016

5

Potassium channel antibodies in two patients with reversible limbic encephalitis

Camilla Buckley, Joel Oger, Linda Clover, Erdem Tüzün, Katherine Carpenter, Matthew Jackson, Angela Vincent

Journal:

Annals of Neurology

Year:

2001

Language:

english

File:

PDF, 2.64 MB

english, 2001

6

Appraisal of the PAM cell effect as a diagnostic test for multiple sclerosis

Howard Cohn, Jôel Oger, Olivier Sabouraud, Maurice Ardouin

Journal:

Annals of Neurology

Year:

1978

Language:

english

File:

PDF, 329 KB

english, 1978

7

Autosomal dominant cerebrovascular amyloidosis: Properties of peripheral blood lymphocytes

Kari Stefansson, Dr. Jack P. Antei, Joel Oger, James Burns, AvertanoB. C. Noronha, Raymond P. Roos, Barry G. W. Arnason, G. Gudmundsson

Journal:

Annals of Neurology

Year:

1980

Language:

english

File:

PDF, 427 KB

english, 1980

8

Cell-mediated immunity in idiopathic polyneuritis

Dr. Aleem Iqbal, Joel J.-F. Oger, Barry G. W. Arnason

Journal:

Annals of Neurology

Year:

1981

Language:

english

File:

PDF, 532 KB

english, 1981

9

Influence of azathioprine (Imuran) on in vitro immune function in multiple sclerosis

Dr. Joel J.-F. Oger, Jack P. Antel, Han Hwa Kuo, Barry G. W. Arnason

Journal:

Annals of Neurology

Year:

1982

Language:

english

File:

PDF, 488 KB

english, 1982

10

Low T8 antigen density on lymphocytes in active multiple sclerosis

Dr Anthony T. Reder, Jack P. Antel, Joël J.-F. Oger, Thomas A. McFarland, Maureen Rosenkoetter, Barry G. W. Arnason

Journal:

Annals of Neurology

Year:

1984

Language:

english

File:

PDF, 720 KB

english, 1984

11

Demyelination and ethnicity: Experience at the University of British Columbia multiple sclerosis clinic with special reference to HTLV-I–associated myelopathy in British Columbian natives

Dr JoëL Oger, Helen Lai

Journal:

Annals of Neurology

Year:

1994

Language:

english

File:

PDF, 239 KB

english, 1994

12

Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis

Dr Donald W. Paty, David K. B. Li, Joël J.-F. Oger, Lorne Kastrukoff, Robert Koopmans, Elizabeth Tanton, Gou Jun Zhao

Journal:

Annals of Neurology

Year:

1994

Language:

english

File:

PDF, 187 KB

english, 1994

13

Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis

Helen Tremlett, Joel Oger

Journal:

Journal of Neurology

Year:

2004

Language:

english

File:

PDF, 226 KB

english, 2004

14

Genetic susceptibility to MS: a second stage analysis in Canadian MS families

David A. Dyment, Cristen J. Willer, Beverly Scott, Holly Armstrong, Arturs Ligers, Jan Hillert, Donald W. Paty, Stanley Hashimoto, Virginia Devonshire, John Hooge, Lorne Kastrukoff, Joel Oger, Luanne

Journal:

Year:

2001

Language:

english

File:

PDF, 47 KB

english, 2001

15

Rapsyn Antibodies in Myasthenia Gravis

MARK A. AGIUS, SHAN ZHU, CHRISTINE A. KIRVAN, ANNE L. SCHAFER, MIKE Y. LIN, ROBERT H. FAIRCLOUGH, JOEL J-F. OGER, TARIQ AZIZ, JOHAN A. AARLI

Journal:

Annals of the New York Academy of Sciences

Year:

1998

Language:

english

File:

PDF, 366 KB

english, 1998

16

A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes

Oger, Joel, Szuchet, Sara, Antel, Jack, Arnason, Barry G. W.

Journal:

Year:

1982

File:

PDF, 671 KB

1982

17

10.1038/80525

Steinman, Lawrence, Kappos, Ludwig, Comi, Giancarlo, Panitch, Hillel, Oger, Joel, Antel, Jack, Conlon, Paul, Comi, Giancarlo, Kappos, Ludwig, Oger, Joel, Panitch, Hillel, Rae-Grant, Alexander, Castald

Journal:

Nature Medicine

Year:

2000

Language:

english

File:

PDF, 133 KB

english, 2000

18

Pyrococcus CH1, an obligate piezophilic hyperthermophile: extending the upper pressure-temperature limits for life

Zeng, Xiang, Birrien, Jean-Louis, Fouquet, Yves, Cherkashov, Georgy, Jebbar, Mohamed, Querellou, Joël, Oger, Philippe, Cambon-Bonavita, Marie-Anne, Xiao, Xiang, Prieur, Daniel

Journal:

The ISME Journal

Year:

2009

Language:

english

File:

PDF, 95 KB

english, 2009

19

Age-related changes in in vitro immunoglobulin secretion: Comparison of responses to T-dependent and T-independent polyclonal activators

Lawrence G. Wrabetz, Jack P. Antel, Joel J-F Oger, Barry G.W. Arnason, Jean-Michel Goust, John E. Hopper

Journal:

Cellular Immunology

Year:

1982

Language:

english

File:

PDF, 436 KB

english, 1982

20

Modulation of T lymphocyte differentiation antigens: Influence of aging

Maureen Rosenkoetter, Jack P. Antel, Joel J-F. Oger

Journal:

Cellular Immunology

Year:

1983

Language:

english

File:

PDF, 463 KB

english, 1983

21

Regulation of in vitro PWM-induced IgG secretion in humans

Maurice R.G. O'Gorman, Joel J.-F. Oger

Journal:

Cellular Immunology

Year:

1989

Language:

english

File:

PDF, 1.33 MB

english, 1989

22

Long-Term Persistence With the Immunomodulatory Drugs for Multiple Sclerosis: A Retrospective Database Study

Charity Evans, Jennifer Tam, Elaine Kingwell, Joel Oger, Helen Tremlett

Journal:

Clinical Therapeutics

Year:

2012

Language:

english

File:

PDF, 621 KB

english, 2012

23

Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNβ in multiple sclerosis patients

Regina Lam, Rachel Farrell, Tariq Aziz, Ebrima Gibbs, Gavin Giovannoni, Sidney Grossberg, Joel Oger

Journal:

Journal of Immunological Methods

Year:

2008

Language:

english

File:

PDF, 380 KB

english, 2008

24

During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4

Erika Basile, Ebrima Gibbs, Tariq Aziz, Joel Oger

Journal:

Journal of Neuroimmunology

Year:

2006

Language:

english

File:

PDF, 203 KB

english, 2006

25

The IgG subclass-specificities of anti-IFNβ antibodies change with time and differ between the IFNβ products in relapsing remitting multiple sclerosis patients

Ebrima Gibbs, Joel Oger

Journal:

Journal of Neuroimmunology

Year:

2007

Language:

english

File:

PDF, 277 KB

english, 2007

26

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Chris H Polman, Antonio Bertolotto, Florian Deisenhammer, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, Joep Killestein, Henry F McFarland, Joel Oger, Andrew R Pachner, John Petkau, Anthony T

Journal:

The Lancet Neurology

Year:

2010

Language:

english

File:

PDF, 206 KB

english, 2010

27

Neutralizing antibodies to interferon beta in multiple sclerosis: Analytical evaluation for validation of a cytopathic effect assay

Catherine Massart, Jacqueline Gibassier, Joël Oger, Emmanuelle Le Page, Gilles Edan

Journal:

Clinica Chimica Acta

Year:

2007

Language:

english

File:

PDF, 466 KB

english, 2007

28

Corrigendum to “Neutralizing antibodies to interferon beta in multiple sclerosis: Analytical evaluation for validation of a cytopathic effect assay” [Clinica Chimica Acta 337 (2007) 185–191]

Catherine Massart, Jacqueline Gibassier, Joël Oger, Emmanuelle Le Page, Gilles Edan

Journal:

Clinica Chimica Acta

Year:

2007

Language:

english

File:

PDF, 82 KB

english, 2007

29

Functional characterization of a C-4 sterol methyl oxidase from the endomycorrhizal fungus Glomus intraradices

Elodie Oger, Stefano Ghignone, Estelle Campagnac, Joël Fontaine, Anne Grandmougin-Ferjani, Luisa Lanfranco

Journal:

Fungal Genetics and Biology

Year:

2009

Language:

english

File:

PDF, 490 KB

english, 2009

30

Interferons in relapsing remitting multiple sclerosis

Mark Freedman, John King, Joel Oger, Mohammad Sharief, Hans-Peter Hartung

Journal:

Year:

2003

Language:

english

File:

PDF, 60 KB

english, 2003

31

A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis

J.Theodore Phillips, George Rice, Elliot Frohman, Luc Vande Gaer, Thomas Scott, Judith Haas, Eric Eggenberger, Mark S Freedman, William Stuart, Luis Cunha, Lawrence Jacobs, Joel Oger, Douglas Arnold,

Journal:

Clinical Therapeutics

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

32

An apparent case of human T-cell lymphotropic virus type II (HTLV-II)-associated neurological disease: a clinical, molecular, and phylogenetic characterisation

Andrew A Peters, Joel J.F Oger, Michael B Coulthart, David J Waters, Heather J Cummings, Gregory A Dekaban

Journal:

Journal of Clinical Virology

Year:

1999

Language:

english

File:

PDF, 365 KB

english, 1999

33

Antibodies to the Acetylcholine Receptor in Myasthenia Gravis Comparison between Human and Fetal Calf Antigen

ROBIN KAUFMAN, JOEL OGER

Journal:

Annals of the New York Academy of Sciences

Year:

1986

Language:

english

File:

PDF, 90 KB

english, 1986

34

A new solid-phase radioimmunoassay to measure IgG secreted by cultured human lymphocytes

Stefano Mariotti, Joel J.-F. Oger, Philippe Fragu, Jack P. Antel, Han-Hwa Kuo, Leslie J. DeGroot

Journal:

Journal of Immunological Methods

Year:

1980

Language:

english

File:

PDF, 544 KB

english, 1980

35

Neutralizing antibodies to poliovirus and mumps virus in amyotrophic lateral sclerosis

James R. Lehrich, Joel Oger, Barry G.W. Arnason

Journal:

Journal of the Neurological Sciences

Year:

1974

Language:

english

File:

PDF, 256 KB

english, 1974

36

HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

Michel Madigand, Joël J.-F. Oger, Renée Fauchet, Oliver Sabouraud, Bernard Genetet

Journal:

Journal of the Neurological Sciences

Year:

1982

Language:

english

File:

PDF, 507 KB

english, 1982

37

Mechanisms responsible for reduced in vitro immunoglobulin secretion in aged humans

Jack P. Antel, Joel J.-F. Oger, Lawrence G. Wrabetz, Barry G.W. Arnason, John E. Hopper

Journal:

Mechanisms of Ageing and Development

Year:

1983

Language:

english

File:

PDF, 457 KB

english, 1983

38

Fluorescence-activated cell sorter analysis of bulk-isolated porcine oligodendrocytes

Elie Smyrnis, Seung U. Kim, Myong W. Kim, Joel Oger, Charles Sylvester, Donald W. Paty

Journal:

Journal of Neuroimmunology

Year:

1986

Language:

english

File:

PDF, 1.30 MB

english, 1986

39

In vitro acetylcholine receptor antibody (ACHRAB) production in myasthenia gravis: Nonspecific reduction with duration of disease

Robin Kaufman, Joel Oger

Journal:

Journal of Neuroimmunology

Year:

1987

Language:

english

File:

PDF, 69 KB

english, 1987

40

Interferon-β downregulates interferon-γ-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells

Hanh K. Huynh, Joel Oger, Katerina Dorovinizis

Journal:

Journal of Neuroimmunology

Year:

1995

Language:

english

File:

PDF, 1.88 MB

english, 1995

41

Immunogenetics of neurological diseases

Joël J.F. Oger, Barry G.W. Arnason

Journal:

Trends in Neurosciences

Year:

1979

Language:

english

File:

PDF, 355 KB

english, 1979

42

HTLV-I associated myelopathy, pathophysiology and relationship with multiple sclerosis

Joël Oger, Gregory Dekaban

Journal:

Clinical Immunology Newsletter

Year:

1994

Language:

english

File:

PDF, 591 KB

english, 1994

43

Immunosuppression: Promises and failures

Journal:

Journal of the Neurological Sciences

Year:

2007

Language:

english

File:

PDF, 124 KB

english, 2007

44

HTLV-1 infection and the viral etiology of multiple sclerosis

Journal:

Journal of the Neurological Sciences

Year:

2007

Language:

english

File:

PDF, 122 KB

english, 2007

45

The implications of immunogenicity for protein-based multiple sclerosis therapies

Bruce A. Cohen, Joel Oger, Alison Gagnon, Gavin Giovannoni

Journal:

Journal of the Neurological Sciences

Year:

2008

Language:

english

File:

PDF, 639 KB

english, 2008

46

Terbutaline in myasthenia gravis: A pilot study

Betty Soliven, Kourosh Rezania, Betul Gundogdu, Barbara Harding-Clay, Joel Oger, Barry G.W. Arnason

Journal:

Journal of the Neurological Sciences

Year:

2009

Language:

english

File:

PDF, 464 KB

english, 2009

47

Insights into origins of Human T-cell Lymphotropic Virus Type 1 based on new strains from aboriginal people of Canada

Anton Andonov, Michael B. Coulthart, Marcos Pérez-Losada, Keith A. Crandall, David Posada, Ruth Padmore, Antonio Giulivi, Joel J. Oger, Andrew A. Peters, Gregory A. Dekaban

Journal:

Infection, Genetics and Evolution

Year:

2012

Language:

english

File:

PDF, 827 KB

english, 2012

48

In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes

Hans D Katzberg, Tariq Aziz, Joel Oger

Journal:

Journal of the Neurological Sciences

Year:

2002

Language:

english

File:

PDF, 273 KB

english, 2002

49

Thymus Histology and Acetylcholine Receptor Antibodies in Generalized Myasthenia Gravis

JOEL J.-F. OGER

Journal:

Annals of the New York Academy of Sciences

Year:

1993

Language:

english

File:

PDF, 145 KB

english, 1993

50

Neutralizing antibodies in multiple sclerosis patients on weekly intramuscular Avonex and biosimilar interferon beta-1a (CinnoVex): Comparing results of measurements in two different laboratories

Shahkarami, Mohammad Amir, Vaziri, Behrouz, Salami, Shiva, Harandi, Ali Amini, Oger, Joel

Journal:

Journal of Immunological Methods

Year:

2013

Language:

english

File:

PDF, 159 KB

english, 2013

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски